Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Autoimmune Disorders

Free Subscription Articles published in Thyroid Retrieve available abstracts of 48 articles: HTML format

Single Articles

February 2026
1. KAHALY GJ, Wolf J, Luffy M, Albert K, et al
   Euthyroidism and Long-Term Remission of Graves' Hyperthyroidism Following Treatment With an FcRn Blocker: A Case Report.
   Thyroid. 2026 Feb 13:10507256261423190. doi: 10.1177/10507256261423190.
   PubMed     Abstract available
   
   
   
2. HAMADI D, Saad-Omer S, Toro-Tobon D, Stan MN, et al
   Beyond the Eyes: Is Teprotumumab Effective for Thyroid Dermopathy?
   Thyroid. 2026;36:213-218.
   PubMed     Abstract available
   
   
   December 2025
3. CHOI S, Shah SV, Chandraparnik P, Wai KM, et al
   Corticosteroids Versus Teprotumumab for the Treatment of Thyroid Eye Disease. Does Either Mitigate the Need for Additional Treatments?
   Thyroid. 2025 Dec 17. doi: 10.1177/10507256251408731.
   PubMed     Abstract available
   
   
   November 2025
4. 
   Corrigendum to: Patterns of Extraocular Muscle Enlargement in Graves' Orbitopathy and Acromegaly.
   Thyroid. 2025 Nov 11. doi: 10.1177/10507256251392924.
   PubMed    
   
   
   October 2025
5. LIU L, Li C, Liu C, Qian T, et al
   Preliminary Evidence of Potential Association Between Exposure to Estriol-Containing Skincare Cosmetics Sold in China and Autoimmune Thyroid Disease.
   Thyroid. 2025 Oct 7. doi: 10.1177/10507256251382545.
   PubMed     Abstract available
   
   
   
6. CARRETTI AL, Kielwasser G, Borson-Chazot F, Peiffert M, et al
   Teprotumumab Treatment in Patients with Steroid and Surgery-Resistant Dysthyroid Optic Neuropathy: A Case Series.
   Thyroid. 2025;35:1202-1207.
   PubMed     Abstract available
   
   
   September 2025
7. POLKAMPALLY S, Halagur AS, Green A, Wei E, et al
   Incidence of Pediatric Graves' Disease in the United States: An Epidemiological Analysis of 2007-2022 Outpatient Insurance Claims.
   Thyroid. 2025 Sep 22. doi: 10.1177/10507256251382559.
   PubMed     Abstract available
   
   
   August 2025
8. CHOU YT, Lai CC, Li CY, Shen WC, et al
   Early Statin Use Following Diagnosis of Graves' Disease Is Associated with a Reduced Risk of Moderate-to-Severe Graves' Orbitopathy in Middle-Aged Adults: Evidence from a Nationwide Taiwanese Cohort.
   Thyroid. 2025 Aug 13. doi: 10.1177/10507256251364782.
   PubMed     Abstract available
   
   
   July 2025
9. CIAMPA DA, Comi S, Cosentino G, Menconi F, et al
   Letter: Prolonged Treatment with Sirolimus (Rapamycin) for Graves' Orbitopathy.
   Thyroid. 2025 Jul 29. doi: 10.1177/10507256251363145.
   PubMed    
   
   
   
10. XIANG P, Latif R, Davies TF
    The Thyrotropin Receptor Antibody Reactome Determines Thyroid and Retro-orbital Responsiveness.
    Thyroid. 2025 Jul 14. doi: 10.1177/10507256251359557.
    PubMed     Abstract available
    
    
    
11. LEI C, Lyu X, Ren Y, Wei D, et al
    Clinical Features of Chinese Patients with Thyroid Eye Disease: A Multicenter Retrospective Study.
    Thyroid. 2025 Jul 14. doi: 10.1177/10507256251359559.
    PubMed     Abstract available
    
    
    June 2025
12. LIU J, Zhu T, Yang L, Qian W, et al
    Cigarette Smoking Drives Thyroid Eye Disease Progression via RAGE Signaling Activation.
    Thyroid. 2025 Jun 12. doi: 10.1089/thy.2025.0062.
    PubMed     Abstract available
    
    
    May 2025
13. VILLAGELIN D, Cooper DS, Burch HB
    Regional Differences in the Management of Thyroid Eye Disease: Results from an International Clinical Practice Survey of Endocrinologists.
    Thyroid. 2025 May 28. doi: 10.1089/thy.2024.0759.
    PubMed     Abstract available
    
    
    April 2025
14. ROZTOCIL E, Husain F, Patrick CC, Feldon SE, et al
    Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye Disease.
    Thyroid. 2025 Apr 21. doi: 10.1089/thy.2024.0529.
    PubMed     Abstract available
    
    
    March 2025
15. BACZEWSKA N, Alexopoulou O, Constantinescu SM, Daumerie C, et al
    Factors Associated with Response to Intravenous Glucocorticoids in Active Moderate-to-Severe Thyroid Eye Disease.
    Thyroid. 2025 Mar 7. doi: 10.1089/thy.2024.0629.
    PubMed     Abstract available
    
    
    February 2025
16. BARTALENA L, Tanda ML
    Is Radioactive Iodine Contraindicated in Patients with Moderate-to-Severe and Active Graves' Orbitopathy?
    Thyroid. 2025 Feb 12. doi: 10.1089/thy.2025.0059.
    PubMed    
    
    
    
17. COSENTINO G, Lanzolla G, Comi S, Maglionico MN, et al
    Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort Study.
    Thyroid. 2025 Feb 5. doi: 10.1089/thy.2024.0633.
    PubMed     Abstract available
    
    
    
18. SMITH TJ
    Controversies Surrounding IGF-I Receptor Involvement in Thyroid-Associated Ophthalmopathy.
    Thyroid. 2025 Feb 5. doi: 10.1089/thy.2024.0606.
    PubMed     Abstract available
    
    
    January 2025
19. CHOU YT, Lai CC, Li CY, Shen WC, et al
    Statin Use and the Risk of Graves' Orbitopathy: A Nationwide Population-Based Cohort Study.
    Thyroid. 2025 Jan 13. doi: 10.1089/thy.2024.0536.
    PubMed     Abstract available
    
    
    December 2024
20. ZAJNER C, Patil N, McInnis R, Van Uum S, et al
    Patterns of Extraocular Muscle Enlargement in Graves' Orbitopathy and Acromegaly.
    Thyroid. 2024 Dec 20. doi: 10.1089/thy.2024.0438.
    PubMed     Abstract available
    
    
    
21. CHO YY, Kim B, Jin SM, Jung CH, et al
    Graves' Disease and the Risk of Type 2 Diabetes: A Korean Population-Based Study.
    Thyroid. 2024 Dec 20. doi: 10.1089/thy.2024.0270.
    PubMed     Abstract available
    
    
    October 2024
22. XIANG P, Latif R, Morshed S, Davies TF, et al
    Hypothyroidism Induced by a TSH Receptor Peptide-Implications for Thyroid Autoimmunity.
    Thyroid. 2024 Oct 22. doi: 10.1089/thy.2024.0089.
    PubMed     Abstract available
    
    
    
23. LEE HS, Lee J, An HJ, Sung MJ, et al
    Mitophagy Defects Exacerbate Inflammation and Aberrant Proliferation in Lymphocytic Thyroiditis.
    Thyroid. 2024 Oct 14. doi: 10.1089/thy.2024.0125.
    PubMed     Abstract available
    
    
    September 2024
24. ELLERVIK C, Boulakh L, Teumer A, Marouli E, et al
    Thyroid function, diabetes, and common age-related eye diseases - a Mendelian randomization study.
    Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0257.
    PubMed     Abstract available
    
    
    
25. RACHMASARI KN, Hamadi D, Thapa P, Bradley E, et al
    The Epidemiology of Thyroid Eye Disease in Olmsted County, Minnesota 2005-2020.
    Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0304.
    PubMed     Abstract available
    
    
    
26. LEE JY, Lee MK, Lee JH, Kim K, et al
    Cancer risks of patients with Graves' disease who received antithyroid drugs as initial treatment: A nationwide population-based analysis.
    Thyroid. 2024 Sep 3. doi: 10.1089/thy.2024.0178.
    PubMed     Abstract available
    
    
    August 2024
27. HANDLER S, Lee SY
    Risk of Progression of Gestational Subclinical Hypothyroidism and Hypothyroxinemia to Overt Hypothyroidism after Pregnancy is Associated with Underlying Thyroid Autoimmunity.
    Thyroid. 2024 Aug 6. doi: 10.1089/thy.2024.0435.
    PubMed     Abstract available
    
    
    June 2024
28. PERAMPALAM S, Wu K, Gild ML, Tacon L, et al
    Association between lymphocytic thyroiditis and papillary thyroid cancer harboring mutant BRAF: a systematic review and meta-analysis.
    Thyroid. 2024 Jun 28. doi: 10.1089/thy.2024.0142.
    PubMed     Abstract available
    
    
    
29. FUNG MHM, Luk Y, Yuen KK, Lang BHH, et al
    The two-year results of using radiofrequency ablation as a novel treatment for persistent or relapsed Graves' disease, a prospective study.
    Thyroid. 2024 Jun 5. doi: 10.1089/thy.2024.0177.
    PubMed     Abstract available
    
    
    
30. KAHALY GJ, Subramanian PS, Conrad E, Holt RJ, et al
    Long-Term Efficacy of Teprotumumab in Thyroid Eye Disease: Follow-Up Outcomes in Three Clinical Trials.
    Thyroid. 2024 Jun 2. doi: 10.1089/thy.2023.0656.
    PubMed     Abstract available
    
    
    April 2024
31. HUANG N, Chen L, Yan Z, Zeng L, et al
    Intracytoplasmic sperm injection versus in vitro fertilization in infertile women with thyroid autoimmunity.
    Thyroid. 2024 Apr 16. doi: 10.1089/thy.2023.0676.
    PubMed     Abstract available
    
    
    
32. SHIN K, Choung H, Lee MJ, Kim J, et al
    A preliminary evaluation of the diagnostic performance of a smartphone-based machine learning-assisted system for evaluation of clinical activity score in digital images of thyroid-associated orbitopathy.
    Thyroid. 2024 Apr 16. doi: 10.1089/thy.2023.0621.
    PubMed     Abstract available
    
    
    
33. SCHEMPP V, Cebeci AN, Reinauer C, Woelfle J, et al
    Neutropenia occurs more often under carbimazole (CBZ) than under methimazole (MMI) treatment in pediatric Graves' disease patients.
    Thyroid. 2024 Apr 13. doi: 10.1089/thy.2023.0673.
    PubMed     Abstract available
    
    
    March 2024
34. LIU S, Lu C, He L, Shan Z, et al
    Vitamin E intake and prevalence rates of thyroid dysfunction and autoimmune thyroiditis: A cross-sectional analysis of NHANES data.
    Thyroid. 2024 Mar 27. doi: 10.1089/thy.2023.0561.
    PubMed     Abstract available
    
    
    February 2024
35. DUNTAS LH
    Reassessing Selenium for the Management of Hashimoto's Thyroiditis: the Selini* shines bright for AIT patients.
    Thyroid. 2024 Feb 18. doi: 10.1089/thy.2024.0078.
    PubMed     Abstract available
    
    
    January 2024
36. HUWILER VV, Maissen-Abgottspon S, Stanga Z, Muehlebach S, et al
    Selenium Supplementation in Patients with Hashimoto Thyroiditis - A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Thyroid. 2024 Jan 20. doi: 10.1089/thy.2023.0556.
    PubMed     Abstract available
    
    
    December 2023
37. PARK SK, Ryoo JH, Kim MH, Jung JY, et al
    Association between eight autoimmune diseases and thyroid cancer: A Nationwide Cohort Study.
    Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0353.
    PubMed     Abstract available
    
    
    
38. SAWIN CT, Cooper DS
    The Origin of Antithyroid Drugs.
    Thyroid. 2023;33:1395-1401.
    PubMed     Abstract available
    
    
    November 2023
39. COHEN-SELA E, Brener A, Raviv O, Yackobovitch-Gavan M, et al
    Outcomes in Maternal Graves' Disease: A Population-Based Mother-Infant Dyad Cohort Study.
    Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0291.
    PubMed     Abstract available
    
    
    
40. FENNEMAN AC, Boulund U, Collard D, Galenkamp H, et al
    Comparative Analysis of Taxonomic and Functional Gut Microbiota Profiles in Relation to Seroconversion of Thyroid Peroxidase Antibodies in Euthyroid Participants.
    Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0346.
    PubMed     Abstract available
    
    
    
41. DOUGLAS RD, Parunakian E, Tolentino J, Malkhasyan E, et al
    A Prospective Study Examining Audiometry Outcomes Following Teprotumumab Treatment for Thyroid Eye Disease.
    Thyroid. 2023 Nov 14. doi: 10.1089/thy.2023.0466.
    PubMed     Abstract available
    
    
    October 2023
42. UYSAL M, Akgun E, Sarioglu AG, Berber E, et al
    Comparison of Perioperative Outcomes in Patients with Graves' Disease Undergoing Total Thyroidectomy with or without Near Infrared Auto-Fluorescence Imaging.
    Thyroid. 2023 Oct 28. doi: 10.1089/thy.2023.0360.
    PubMed     Abstract available
    
    
    
43. KO J, Kim YJ, Choi SH, Lee CS, et al
    Yes-associated protein (YAP) mediates the transition from inflammation to fibrosis in Graves' orbitopathy.
    Thyroid. 2023 Oct 6. doi: 10.1089/thy.2023.0309.
    PubMed     Abstract available
    
    
    
44. 
    Correction to: Response to Mooij and van Trotsenburg re: ''Exploring the Genetic Link Between Thyroid Dysfunction and Common Psychiatric Disorders: A Specific Hormonal or a General Autoimmune Comorbidity'' by Medici and Soheili-Nezhad. Thyroid 2023;33
    Thyroid. 2023 Oct 5. doi: 10.1089/thy.2023.0315.
    PubMed    
    
    
    September 2023
45. PAPADOPOULOU A, Asvold BO, Burgess S, Kus A, et al
    Height, autoimmune thyroid disease and thyroid cancer: a Mendelian randomisation study.
    Thyroid. 2023 Sep 29. doi: 10.1089/thy.2023.0272.
    PubMed     Abstract available
    
    
    
46. KHAMISI S, Udumyan R, Sjolin G, Calissendorff J, et al
    Fracture incidence in Graves' disease: A population-based study.
    Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0162.
    PubMed     Abstract available
    
    
    
47. DE LEO S, D'Elia S, Grani G, Dondi F, et al
    A Prospective, Multicenter Study Examining the Relationship between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis.
    Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0052.
    PubMed     Abstract available
    
    
    July 2023
48. TORO-TOBON D, Rachmasari K, Bradley E, Wagner L, et al
    Medical Therapy in Patients with Moderate to Severe, Steroid-resistant, Thyroid Eye Disease.
    Thyroid. 2023 Jul 29. doi: 10.1089/thy.2023.0167.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum